cancer - search results

The power of flexible teamwork is the key to successful research in chemical biology and drug discovery in the work of Professor Colin Suckling at the Department of Pure and Applied Chemistry at the University of Strathclyde in Glasgow. Over the past 10 years, research has challenged major problems of...

Adnan Sharif, Consultant Nephrologist at University Hospitals Birmingham discusses kidney transplants and the impact it has on the patient and their quality of life. Chronic kidney disease affects over 10% of the UK population and can progress to end-.stage kidney disease, requiring renal replacement therapy in the form of either...

AG (May 2014) "I was more than happy to provide comment on the work of the Institute when asked by AG. I am also pleased to see the wider issue of stem cell research addressed within the publication and hope that it helps the readership to see how life-changing this...

AG (May 2014) "Thanks for sending through the link - I think the publication is fab and we fit really well within the stem cell section. I will certainly add a link to the article, both on our website and on Twitter. Please don't hesitate to contact me again in the...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute gives an overview of how cancer stem cells differ from the conventional stem cell. Cancer remains one of the major challenges in terms of life expectancy and is recognised as the second largest cause of mortality within the...

From stem cell biology to tissue mending In the last 25 years, tremendous advances have been made in the identification and generation of stem cells (SC) from diverse organisms, generating a wealth of knowledge in various fields from embryology to development. SC not only have the ability to differentiate into...

Paul Cribbens, Standards Manager at NHBC outlines the development of new standards and guidance for MVHR systems following research that suggests installations and design are under-performing. The move towards higher levels of energy efficiency in new homes and improved airtightness has led to around a quarter of new homes built being...

Emma Greenwood, head of policy development at Cancer Research UK explains the importance of early diagnosis for cancer within local communities. Cancer remains a major focus for the health service in England and, after the Health and Social Care Act came into force earlier this year, local authorities have an even...

The Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology (CIBIO) of the University of Trento, Italy, is focusing on RNA to develop better diagnostic tools and therapeutics for a range of genetic diseases and cancers. The research projects developed in the laboratory also aim at...

All available data shows that, despite a better understanding of the biology of tumour cells, the treatment of most cancers has not significantly changed for the past three decades. For the main types of cancer, survival rates for people diagnosed when their tumours were in an advanced stage has changed...

Understanding liver cancer development in Europe: Novel mouse models for pre-clinical trials. Today, liver cancer – also called hepatocellular carcinoma (HCC) – reflects the 3rd most common cause for cancer related death world-wide with approximately 800.000 deaths per year. In stray African or Asian countries HCC has become the most common...

Hepatocarcinogenesis and future challenges: Pre-clincial models for virus- or high fat diet-induced liver cancer.